Published in Blood Weekly, January 20th, 2000
Vascular endothelial growth factor (VEGF) is a potent mitogen for vascular endothelial cells. VEGF has been associated with angiogenesis, growth, dissemination, metastasis, and poor outcome in solid tumors.
A. Aguayo and colleagues performed a study to assess cellular VEGF levels and their prognostic significance in newly diagnosed acute myeloid leukemia (AML) ("Cellular Vascular Endothelial Growth Factor Is a Predictor of Outcome in Patients with Acute Myeloid...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.